TOMI Environmental Solutions Seizes Momentum in 2025 with Breakthroughs in Life Sciences and Food Safety
The year 2025 was a pivotal moment for TOMI Environmental Solutions, Inc. as it witnessed significant milestones in its SteraMist Integrated System (SIS) platform and other technologies. In a recent conference call, Dr. Halden Shane, CEO and Chairman of the Board, highlighted the company's progress and optimism for the future.
The SIS platform achieved its first commercial installation at a leading Contract Development and Manufacturing Organization (CDMO) in June 2025, marking a significant proof-of-concept milestone. By year-end, four fully operational SIS enclosure installations were completed, demonstrating the technology's viability. A signed purchase contract of $500,000 from a global biopharmaceutical leader in December for integration into sterile manufacturing pass-through fill boxes further solidified the company's position.
A landmark win in the cell and gene therapy sector came with the adoption of SteraMist iHP by a leading manufacturer for a commercial-scale pharmaceutical facility. This achievement underscores TOMI's expanding presence in one of the fastest-growing sectors of life sciences manufacturing. Additionally, the company secured a contract from NASA Johnson Space Center for biosecurity operations, where their technology continues to perform satisfactorily.
In response to wildfire recovery efforts in California communities, TOMI deployed critical resources, showcasing its civic commitment and operational agility. A leading university in Rhode Island selected TOMI's CES technology for a project that has been completed and awaits factory testing. Furthermore, one of the company's prominent platinum customers in the eye health sector expanded to 2 active facilities each utilizing 5 SteraMist machines for sterilization procedures, with a third site set to commence trials in June 2026.
TOMI's OEM partnership strategy is gaining momentum, particularly through relationships with PBSC, ESCO, and Steelco. These partnerships embed IHP directly into cleanroom enclosures, pass-through hatches, and biosafety cabinets at the point of manufacture, expanding reach without proportionally increasing direct sales costs. A successful collaboration project with PBSC exceeded decontamination cycle speed expectations and generated strong customer feedback.
The FDA's approval of hydrogen peroxide as a direct food additive for multiple uses marks a significant regulatory moment for TOMI. The company is now engaged with significant partners, including Danone and Nestlé, actively winning bids both directly and through service providers. SteraMist iHP has demonstrated real-world efficacy across various food processing environments.
TOMI's CEO Dr. Halden Shane emphasized that while 2025 tested the company's patience, it also validated their technology, deepened customer relationships, and positioned them for meaningful revenue opportunities in 2026 and beyond. As TOMI continues to push forward with its innovative technologies and expanding partnerships, optimism is high regarding the future prospects of this environmental solutions provider.
